EMT marker | Function | CRPC | Refs |
---|---|---|---|
E-cadherin | Regulates the invasive capacity of prostate cancer cells | Â | |
β-Catenin | Regulates the process of EMT and metastatic phenotypes |  | [59] |
N-cadherin | Promotes growth, metastasis and castration resistance in prostate cancer | Yes | |
Cadherin-11 | Enhances migration and invasion capacity of prostate cancer cells, increases the association with osteoblasts | Â | |
Vimentin | Promotes prostate cancer cell invasion and metastasis | Yes | [63] |
Fibronectin | Protects cells from undergoing apoptosis | Â | |
Collagen 1 | Have an effect on EMT of prostate cancer cells | Â | [65] |
alphaII(b)beta3 integrin | Participates in the metastatic progression of prostatic adenocarcinoma | Â | [66] |
Syndecan-1 | Associates with Gleason score and tumor progression of prostate cancer | Â | |
Zeb1 | Altering the invasive phenotype of Prostate cancer cells | Yes | |
Slug | Correlates with advanced pathological grades of prostate cancer | Yes | |
Snail | Contributes to prostate cancer progression and metastasis | Â | |
Twist | Correlates with Gleason grading and metastasis | Yes | |
ETS-1 | Mediates by TGF-β, affects cell growth and tumor formation | Yes | |
CSC markers | Function | CRPC | Refs |
Lgr4 | Regulates early prostate development and stem cell differentiation | Â | [32] |
α2β1 integrin | Produces prostate-like glands |  | [30] |
CD133 | Functions as a normal prostate stem cell marker and has tumor formation ability | Â | [76] |
CD166 | A potential surface marker for castration resistant tumor cells | Yes | [21] |
PSA | Displays increased colony and sphere-form capacity | Yes | [22] |
CD44 | Associates with cells of neuro-endocrine phenotype | Â | [77] |
CD44+/α2β1hi/CD133+ | Presents high proliferative ability in vitro and can differentiate to an AR–positive phenotype similar to prostate cancers in vivo |  | [78] |
CD44+ CD24(-) | Exhibits stem cell characteristics and predicts overall survival in prostate cancer patients. | Â | [79] |
Sca-1 | Have high proliferative ability and high capacity to reconstitute prostatic tissue | Â | [31] |
Nkx3.1 | Indicates that luminal cells might be a cell of origin | Yes | [20] |
p63 | Produces all epithelial lineages of the adult prostate (i.e., basal, luminal, and neuroendocrine cells) | Â | |
Lin-Sca-1-CD49f+ (LSC) | Produces prostatic tubule structures | Â | [82] |
Lin-CD44+CD133+Sca-1+CD117+ | Produces a prostate after transplantation in vivo | Â | [29] |
Trop2 | Trop2hi basal cells give rise to basal, luminal, and neuroendocrine cells in vivo | Â | [83] |
ALDH1 | Associates with a poor prognosis for patients with prostate cancer | Â | |
Nanog | Promotes CSC phenotypes and properties in vitro and in vivo, promotes AI phenotypes and CRPC regeneration | Yes | |
Bmi-1 | A key regulator of self-renewal activity, plays central roles in malignant progression of prostate cancer | Yes | [26] |
Sox2 | Inhibits by AR signaling and play an important role in CRPC | Yes | [28] |
TRA-1-60, CD151 and CD166 | Exhibits enhanced sphere-forming capacities in vitro and tumor-initiation capacities in vivo | Â | [86] |
Signal pathway involved CSC and EMT | Function | CRPC | Refs |
AR | A key regulator for the acquisition of EMT phenotypes | Yes | |
PTEN/AKT | Promotes prostate tumor growth and metastasis | Â | [87] |
AKT/GSK-3β | Participates in TNFα-induced EMT process |  | [88] |
ERK | Has a profound feedback on EGFR signaling | Â | [89] |
AKT | Has a great effect on cell migration via induction of the EMT characteristics | Â | [89] |
TGF-β | Associates with malignant progression of prostate cancer by activation of the EMT phenotypes |  | |
CCL2/CCR2-STAT3 | Promotes prostate cancer cell migration/invasion and EMT pathways | Yes | [92] |
Hsp27-STAT3-Twist | Promotes prostate cancer metastasis, regulates the process of EMT | Yes | [39] |
PTEN and RAS/MAPK | Accelerates prostate cancer malignant progression accompanied by acquisition of EMT phenotypes and stem-cell like properties | Yes | [37] |
NF-kappaB | Correlates with EMT in human prostate cancer cells and may be functionally associated with the stem-like human prostate tumor initiation cells | Â | |
JAK-STAT | Participates in significantly different gene expression in prostate cancer stem cells | Â | [95] |
PDGF-D | Mediates EMT process and regulates cancer cell invasion | Â | [96] |
IGF-1 | Regulates EMT associated migration and invasion via elevated Zeb1 expression | Yes | [8] |
FGFR-1 | Leads to an EMT and distant metastasis | Â | [38] |
EGFR | Presents loss of cell-cell junctions with decreased epithelial markers and enhanced mesenchymal markers | Â | [89] |
WNT | Mediates EMT phenotypes and stemness maintenance of prostate cancer cells | Yes | |
Notch and Hedgehog | Regulates drug resistance and plays important roles in malignant transformation | Yes | |
Hypoxia-ERβ-HIF-1a/VEGF-A | Mediates EMT and have an implication in Gleason grading |  | [100] |
DAB2IP | Regulates EMT and prostate cancer metastasis and serves as a target gene of EZH2 in prostatic epithelium | Â | |
p63/miR205 | Suppresses cell migration and metastasis | Â | [104] |
 | Produces changes in Golgi polarization |  |  |